SCHEMBL8875102

SCHEMBL8875102

COc1ccccc1C1(O)C(C)CCC2CNCC21

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.45
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
KMT2A Q03164 1/20 0.37
HTR2C P28335 2/20 0.35
PDK2 Q15119 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
OPRL1 P41146 1/20 0.34
NPY1R P25929 1/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8874651 0.88 SIGMAR1 (0.46) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL5809783 0.78 SIGMAR1 (0.54) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL8873371 0.77 SIGMAR1 (0.48) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL8875726 0.73 SIGMAR1 (0.44) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL8874373 0.73 SIGMAR1 (0.44) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL8874988 0.73 SIGMAR1 (0.44) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL8873941 0.73 MEN1 (0.46) SIGMAR1CHRM4KMT2A
SCHEMBL8874747 0.73 SIGMAR1 (0.46) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL9281012 0.70 SIGMAR1 (0.43) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL8893688 0.70 SIGMAR1 (0.43) SIGMAR1CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624950-A USEFUL IN TREATMENT OF ANALGESIA, INFLAMMATION, ASTHMA, ALLERGIES, CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS, IMMUNE SYSTEM DISORDERS, ANTISPASMODIC AGENTS, ANTIEMETIC AGENTS RHONE-POULENC RORER S.A. (FR) 1997-04-29 US disclosed